|1.||Skiljević, Dušan: 1 article (01/2011)|
|2.||Popadić, Svetlana: 1 article (01/2011)|
|3.||Medenica, Ljiljana: 1 article (01/2011)|
|4.||Milenković, Branislava: 1 article (01/2011)|
|5.||Antić, Darko: 1 article (01/2011)|
|6.||Monteón-Padilla, Víctor Manuel: 1 article (01/2004)|
|7.||Reyes, Pedro Antonio: 1 article (01/2004)|
|8.||Cruz-Robles, David: 1 article (01/2004)|
|9.||Ortiz-Muñiz, Alda Rocío: 1 article (01/2004)|
|10.||Vargas-Alarcón, Gilberto: 1 article (01/2004)|
01/01/1999 - "Previous studies indicated the increase of HLA-B39 among HLA-B27 negative patients with spondylarthropathies (SpA). "
11/01/1995 - "Because HLA-B27 and HLA-B39 share Glu at position 45 and Cys at position 67, both of which constitute components of the peptide-anchoring B pocket, and because they possess similar peptide-ligand motifs, our results may support either the role of the peptides presented by class I antigens or the importance of Cys at position 67, in the development of spondylarthropathies and pauciarticular-onset JRA."
06/01/1995 - "Univariate analysis revealed that the HLA antigens B27, B39, and DQw3 were associated with disease progression, while HLA-DR7 was "protective." The best multivariate model identified the HLA antigens B27, when DR7 was present, and DQw3, when DR7 was not present, as predicting disease progression across all transitions, while HLA-B39 was associated with progression in early disease. "
04/01/1998 - "Only HLA-B22 was added to the original model, which includes HLA-B39, providing risk for progression in early stages, HLA-B27 in the presence of HLA-DR7 providing risk for progression through all states, and DQw3 providing increased risk in the absence of DR7, while in the presence of DR7 it provides "protection." HLA-B22 provides protection from disease progression through all states. "
01/01/1987 - "The hypothesis is formulated that HLA-B39 may discriminate a genetic subset of psoriatic arthritis characterized by a particular susceptibility to develop axial involvement."
01/01/1987 - "HLA-B39 and the axial type of psoriatic arthritis."
01/01/1987 - "The frequency distribution of HLA-B38 and HLA-B39 was studied in a group of 50 unrelated psoriatic arthritis patients. "
|5.||Renal Artery Obstruction (Renal Artery Stenosis)
|1.||HLA-B27 Antigen (HLA B27 Antigen)
|2.||HLA-DR7 Antigen (HLA DR7 Antigen)
|3.||HLA-DR4 Antigen (HLA DR4 Antigen)
|4.||Histocompatibility Antigens Class I
|6.||HLA Antigens (Human Leukocyte Antigens)
|9.||HLA-DRB1 antigen (HLA DRB1)